Shuttle Pharmaceuticals Holdings, Inc. (SHPH)
USD 0.41
(-8.56%)
USD 0.41
(-8.56%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 5.95 Million USD | -31.22% |
| 2022 | 8.65 Million USD | 1227.96% |
| 2021 | 651.64 Thousand USD | 19.78% |
| 2020 | 544.04 Thousand USD | 0.0% |
| 2018 | 621.27 Thousand USD | 412.19% |
| 2017 | 121.29 Thousand USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 2.81 Million USD | -40.83% |
| 2024 Q1 | 4.75 Million USD | -20.13% |
| 2023 Q1 | 10.43 Million USD | 20.6% |
| 2023 Q3 | 7.37 Million USD | -16.54% |
| 2023 FY | 5.95 Million USD | -31.22% |
| 2023 Q4 | 5.95 Million USD | -19.31% |
| 2023 Q2 | 8.83 Million USD | -15.33% |
| 2022 Q4 | 8.65 Million USD | -7.76% |
| 2022 FY | 8.65 Million USD | 1227.96% |
| 2022 Q2 | 173.48 Thousand USD | -68.6% |
| 2022 Q1 | 552.44 Thousand USD | -15.22% |
| 2022 Q3 | 9.38 Million USD | 5308.13% |
| 2021 FY | 651.64 Thousand USD | 19.78% |
| 2021 Q4 | 651.64 Thousand USD | 0.0% |
| 2020 FY | 544.04 Thousand USD | 0.0% |
| 2018 FY | 621.27 Thousand USD | 412.19% |
| 2017 FY | 121.29 Thousand USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Journey Medical Corporation | 76.84 Million USD | 92.255% |
| ANI Pharmaceuticals, Inc. | 904.42 Million USD | 99.342% |
| Aquestive Therapeutics, Inc. | 57.41 Million USD | 89.634% |
| Pacira BioSciences, Inc. | 1.57 Billion USD | 99.622% |
| Sunshine Biopharma, Inc. | 27.34 Million USD | 78.236% |
| Sunshine Biopharma, Inc. | 27.34 Million USD | 78.236% |
| SCYNEXIS, Inc. | 128.41 Million USD | 95.365% |
| Safety Shot Inc | 12.7 Million USD | 53.17% |
| Alpha Teknova, Inc. | 128.58 Million USD | 95.371% |
| Collegium Pharmaceutical, Inc. | 1.14 Billion USD | 99.479% |
| Bright Green Corporation | 17.4 Million USD | 65.801% |
| Dynavax Technologies Corporation | 997.09 Million USD | 99.403% |
| Esperion Therapeutics, Inc. | 205.79 Million USD | 97.108% |
| Cosmos Health Inc. | 66.29 Million USD | 91.022% |
| PainReform Ltd. | 9.93 Million USD | 40.063% |
| China SXT Pharmaceuticals, Inc. | 23.12 Million USD | 74.265% |
| Embecta Corp. | 1.21 Billion USD | 99.51% |
| Intra-Cellular Therapies, Inc. | 728.29 Million USD | 99.183% |
| Procaps Group, S.A. | 460.18 Million USD | 98.707% |
| Theratechnologies Inc. | 77.76 Million USD | 92.347% |
| Harrow Health, Inc. | 311.75 Million USD | 98.091% |
| Sonoma Pharmaceuticals, Inc. | 14.89 Million USD | 60.037% |
| Biofrontera Inc. | 27.93 Million USD | 78.692% |
| DURECT Corporation | 45.18 Million USD | 86.829% |
| Supernus Pharmaceuticals, Inc. | 1.4 Billion USD | 99.578% |
| Cronos Group Inc. | 1.13 Billion USD | 99.475% |
| OptiNose, Inc. | 107.72 Million USD | 94.475% |
| Ironwood Pharmaceuticals, Inc. | 471.07 Million USD | 98.737% |
| Kala Pharmaceuticals, Inc. | 55.94 Million USD | 89.362% |
| RedHill Biopharma Ltd. | 23.04 Million USD | 74.176% |
| Organogenesis Holdings Inc. | 460.02 Million USD | 98.706% |
| Guardion Health Sciences, Inc. | 11.91 Million USD | 50.062% |
| Cumberland Pharmaceuticals Inc. | 81.77 Million USD | 92.722% |
| Radius Health, Inc. | 1.71 Billion USD | 99.653% |
| Universe Pharmaceuticals INC | 53.28 Million USD | 88.831% |
| ProPhase Labs, Inc. | 91.92 Million USD | 93.526% |
| Phibro Animal Health Corporation | 982.18 Million USD | 99.394% |
| Procaps Group S.A. | 460.18 Million USD | 98.707% |
| Alvotech | 950.09 Million USD | 99.374% |
| TherapeuticsMD, Inc. | 43.3 Million USD | 86.258% |
| Viatris Inc. | 47.68 Billion USD | 99.988% |
| Rockwell Medical, Inc. | 52.17 Million USD | 88.592% |
| Aytu BioPharma, Inc. | 118.09 Million USD | 94.96% |
| SIGA Technologies, Inc. | 254.83 Million USD | 97.664% |
| Tilray Brands, Inc. | 4.33 Billion USD | 99.863% |
| Lifecore Biomedical, Inc. | 273.7 Million USD | 97.825% |
| Shineco, Inc. | 84.17 Million USD | 92.93% |
| PetIQ, Inc. | 868.22 Million USD | 99.314% |
| Regencell Bioscience Holdings Limited | 8.43 Million USD | 29.467% |
| Incannex Healthcare Limited | 17.04 Million USD | 65.086% |
| Neurocrine Biosciences, Inc. | 3.25 Billion USD | 99.817% |
| Alimera Sciences, Inc. | 153.52 Million USD | 96.123% |
| Silver Spike Investment Corp. | 88.57 Million USD | 93.281% |
| Assertio Holdings, Inc. | 286.41 Million USD | 97.922% |
| Petros Pharmaceuticals, Inc. | 33.79 Million USD | 82.389% |
| Clever Leaves Holdings Inc. | 31.24 Million USD | 80.95% |
| Cyclo Therapeutics, Inc. | 13.24 Million USD | 55.073% |
| Avadel Pharmaceuticals plc | 261.12 Million USD | 97.721% |
| Hempacco Co., Inc. | 18.04 Million USD | 67.014% |
| Talphera, Inc. | 20.39 Million USD | 70.818% |
| Alvotech | 950.09 Million USD | 99.374% |
| Eagle Pharmaceuticals, Inc. | 406.16 Million USD | 98.535% |
| Lantheus Holdings, Inc. | 1.65 Billion USD | 99.64% |
| Currenc Group, Inc. | 141.49 Million USD | 95.794% |
| Kamada Ltd. | 351.96 Million USD | 98.309% |
| Indivior PLC | 1.95 Billion USD | 99.695% |
| Evoke Pharma, Inc. | 7.06 Million USD | 15.8% |
| Flora Growth Corp. | 23.62 Million USD | 74.809% |
| Cyclo Therapeutics, Inc. | 13.24 Million USD | 55.073% |
| Evolus, Inc. | 188.99 Million USD | 96.851% |
| HUTCHMED (China) Limited | 1.27 Billion USD | 99.535% |
| Amphastar Pharmaceuticals, Inc. | 1.51 Billion USD | 99.607% |
| Akanda Corp. | 8.83 Million USD | 32.673% |